Preserva offers the Evalin‑E1, a handheld insulin effectiveness tester that lets people with diabetes quickly check whether their insulin has degraded. By providing on‑the‑spot results, the device helps users avoid unexpected blood‑sugar spikes and costly emergency visits caused by denatured insulin. The tester is designed for home use, delivering fast, accurate readings to support safer insulin management.
Funding
Funding not disclosed
Founders
Product
Problem
People with diabetes risk using insulin that has lost potency, which can cause unexpected blood‑sugar spikes, ineffective dosing, and unnecessary emergency‑room visits. Currently there is no simple, at‑home method to verify insulin effectiveness before injection.
Solution
Preserva offers a handheld insulin effectiveness tester that allows users to assess whether their insulin has degraded directly from home. The device delivers rapid, quantitative results using a built‑in assay that detects loss of insulin activity. By confirming potency before each injection, users can avoid ineffective doses and reduce the likelihood of acute hyperglycemia. The tester is designed for easy, point‑of‑care use without specialized training, providing a reliable safety check for daily diabetes management.
Target Audience
Primary customers are individuals with diabetes who self‑administer insulin, as well as caregivers and home health providers responsible for insulin therapy.
Features
- Compact, battery‑operated handheld form factor for bedside or travel use
- Integrated assay technology that measures insulin activity within minutes
- Simple one‑button operation with clear pass/fail indicator
- Results displayed on an LCD screen and stored locally for tracking over time
- Compatible with standard insulin vials and pens from major manufacturers